Sulis Therapeutics ApS — CVR 44445832
Is this your company?
Verify ownership and add your website, description, services, products, logo, socials and more.
Claim & enrichReviews
Loading…
Verified reviews from Søge users
Company relationship network
Building the network…
Node colour = company status · blue dot = person. Edge colour = how they are linked: ownership, management, founder, or a shared phone / e-mail / website. Toggle any relation type off with the filters. Double-click a company to open it.
Active
Founded 2023
CVR
44445832
↗ Datacvr
Status
Active
Company form
Private limited (ApS)
Start date
2023-11-21
Addresses
Ole Maaløes Vej 3, 2200 København N
(KØBENHAVN)
Advertising protected
Yes
Industry (3)
Fremstilling af farmaceutiske præparater
212000
Forskning og eksperimentel udvikling indenfor bioteknologi
721100
Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
721000
Addresses (4)
Inge Lehmanns Gade 10,
8000 Aarhus C
(AARHUS)
2023-11-21
Inge Lehmanns Gade 10,
8000 Aarhus C
(AARHUS)
2024-02-29
Ole Maaløes Vej 3,
2200 København N
(KØBENHAVN)
2024-09-05
Ole Maaløes Vej 3,
2200 København N
(KØBENHAVN)
2024-09-17
Relations (15)
Claus Elsborg Olesen
DirectorBoard member
Profile
Sten Verland
Board memberChairman
Profile
Morten Døssing
Board member
Profile
Martin Roelsgaard Jakobsen
Board member
Profile
Christian Schetter
Chairman
Profile
Natalie Rose Sacks
Board member
Profile
CLAUS OLESEN HOLDING ApS
Legal owner
Profile
Ownership: 10%
· Voting: 10%
KR 483 A/S
Auditor
Profile
Kommanditselskabet af 26. juni 2017
Legal owner
Profile
Ownership: 20%
· Voting: 20%
MR Jakobsen Holding ApS
Legal owner
Profile
Ownership: 10%
· Voting: 10%
STIPE Therapeutics ApS
FoundersLegal owner
Profile
Ownership: 100%
· Voting: 100%
Regina Hodits
Board member
Profile
Ownership: 20%
· Voting: 20%
Shinka Life Sciences AB
Legal owner
Profile
Ownership: 25%
· Voting: 25%
Name history (2)
Selskabet af 21. november 2023 ApS
2023-11-21 — 2024-06-26
Sulis Therapeutics ApS
2024-06-27
Lifecycle (1)
2023-11-21 — now
Employees per month
| Period | Employees | FTE (man-years) |
|---|---|---|
| 2026-05 | 2 | 1.6 |
| 2026-04 | 2 | 1.81 |
| 2026-03 | 2 | 1.3 |
| 2026-02 | 2 | 1.43 |
| 2026-01 | 2 | 1.37 |
| 2025-12 | 2 | 0.91 |
| 2025-11 | 2 | 1.77 |
| 2025-10 | 2 | 1.59 |
| 2025-09 | 2 | 0.79 |
| 2025-08 | 2 | 0.84 |
| 2025-07 | 2 | 0.76 |
| 2025-06 | 2 | 0.91 |
| 2025-05 | 2 | 0.87 |
| 2025-04 | 2 | 0.91 |
| 2025-03 | 2 | 0.83 |
| 2025-02 | 2 | 0.87 |
| 2025-01 | 2 | 0.79 |
| 2024-12 | 2 | 0.96 |
| 2024-11 | 2 | 0.83 |
| 2024-10 | 2 | 0.76 |
| 2024-09 | 2 | 0.83 |
Production units (1)
Registration history
2024-09-17
Addresses
2024-09-05
Addresses
2024-06-27
Name history: Sulis Therapeutics ApS
2024-02-29
Addresses
2023-11-21
Addresses
2023-11-21
Name history: Selskabet af 21. november 2023 ApS
2023-11-21
Company registered
Attributes
Owner registration under 5%
No
Purpose
Selskabets formål er udvikling og kommercialisering af lægemidler og hermed forbundet virksomhed.
First financial period end
2023-12-31
First financial period start
2023-11-21
Registered capital
100,000 DKK
Share classes
No
Capital currency
DKK
Partly paid capital
No
Covered by AML/CTF act
Not covered
Pseudo CVR number
No
Financial year end
31.12
Financial year start
01.01
Audit opted out
No
Signing rule
Selskabet tegnes af formanden for bestyrelsen i forening med en direktør, af to bestyrelsesmedlemmer i forening eller af den samlede bestyrelse.; Selskabet tegnes af en direktør; Selskabet tegnes af bestyrelsesformanden i forening med et bestyrelsesmedlem, eller af den samlede bestyrelse.
Latest articles date
2023-11-21; 2024-06-27; 2025-08-05
Similar companies
Searching...
Didn't find what you need? Try searching
Vehicles